Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities

Real-life effectiveness of mepolizumab in patients with severe refractory eosinophilic asthma and multiple comorbidities

Background: Data on mepolizumab in patients with severe eosinophilic asthma (EA) and comorbidities are needed to assess whether randomized controlled trial results are applicable in the real world. Objective: To evaluate real-life effectiveness and the presence/absence of predictors of treatment res...

Full description

Bibliographic Details
Main Authors: Claudia Crimi, Raffaele Campisi, Giulia Cacopardo, Rossella Intravaia, Santi Nolasco, Morena Porto, Corrado Pelaia, Nunzio Crimi
Format: Article
Language:English
Published: Elsevier 2020-09-01
Series:World Allergy Organization Journal
Subjects:
Mepolizumab
Severe eosinophilic asthma
Multiple comorbidities
Online Access:http://www.sciencedirect.com/science/article/pii/S1939455120303653

Internet

http://www.sciencedirect.com/science/article/pii/S1939455120303653

Similar Items